These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3534782)

  • 1. Enhanced endothelial cell proliferation in acute Kawasaki disease (muco-cutaneous lymph node syndrome).
    Hashimoto Y; Yoshinoya S; Aikawa T; Mitamura T; Miyoshi Y; Muranaka M; Miyamoto T; Yanase Y; Kawasaki T
    Pediatr Res; 1986 Oct; 20(10):943-6. PubMed ID: 3534782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Kawasaki disease on migration of human umbilical vein endothelial cells.
    Sakata K; Kita M; Imanishi J; Onouchi Z; Liu Y; Mitsui Y
    Pediatr Res; 1995 Oct; 38(4):501-5. PubMed ID: 8559600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IgG subclasses in the serum and circulating immune complexes in patients with Kawasaki disease].
    Li CR
    Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):578-81, 40. PubMed ID: 2620267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased circulating endothelial progenitor cell function: relationship with serum concentrations of high-sensitivity C-reactive protein in children with Kawasaki disease].
    Xu MG; Men LN; Wang HX; Zu Y; Zhao CY; Zhao X; Cai HB; Meng XC; Wang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):513-7. PubMed ID: 20637144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).
    Lin CY; Hwang B
    Ann Allergy; 1987 Oct; 59(4):291-7. PubMed ID: 3662131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Circulating interleukin-4 levels in acute phase Kawasaki disease].
    Hirao J; Hibi S; Andoh T; Ichimura T
    Arerugi; 1996 Oct; 45(10):1137-9. PubMed ID: 8958662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
    J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal histology of mucocutaneous lymph node syndrome (Kawasaki disease).
    Salcedo JR; Greenberg L; Kapur S
    Clin Nephrol; 1988 Jan; 29(1):47-51. PubMed ID: 3289806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibody-dependent cell-mediated cytotoxicity (K-cell population) of peripheral lymphocytes in Kawasaki disease and allergic conditions. 1. Relation between K-cell population and the blood immune complex content in Kawasaki disease].
    Suzuki M
    Arerugi; 1983 Mar; 32(3):164-72. PubMed ID: 6625894
    [No Abstract]   [Full Text] [Related]  

  • 11. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
    Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
    J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Kawasaki disease(muco-cutaneous lymph node syndrome)].
    Kusakawa S
    Nihon Rinsho; 1976 Feb; 34(2):306-10. PubMed ID: 944291
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of immune complexes in Kawasaki disease].
    Yanase Y; Kawasaki T; Yoshinoya S; Aikawa T; Hashimoto Y; Mitamura T; Miyoshi Y; Muranaka M; Miyamoto T
    Arerugi; 1984 Jan; 33(1):59-65. PubMed ID: 6743029
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of Kawasaki disease (muco-cutaneous lymph node syndrome)].
    Yanagawa H
    Nihon Rinsho; 1976 Feb; 34(2):275-83. PubMed ID: 944285
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
    Ueno K; Nomura Y; Hashiguchi T; Masuda K; Morita Y; Hazeki D; Eguchi T; Maruyama I; Kawano Y
    Br J Haematol; 2010 Jan; 148(2):285-92. PubMed ID: 19793253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
    Maury CP; Salo E; Pelkonen P
    J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arteritis in muco-cutaneous lymph node syndrome Kawasaki disease - its comparison with infantile periarteritis nodosa].
    Tanaka N; Sekimoto K; Naoe S
    Nihon Rinsho; 1976 Feb; 34(2):259-68. PubMed ID: 4636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiological studies of Kawasaki disease (muco-cutaneous lymph node syndrome)].
    Shigematsu I
    Nihon Rinsho; 1976 Feb; 34(2):284-9. PubMed ID: 944286
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune complexes in Kawasaki syndrome: a review.
    Pachman LM; Herold BC; Davis AT; Hang LM; Schaller JG; Beckwith B; Arroyave CM; Gawryl MS; Lint T; Shulman ST
    Prog Clin Biol Res; 1987; 250():193-207. PubMed ID: 3321076
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum interleukin-2 receptor in patients with Kawasaki disease].
    Matsubara T
    Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.